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Abstract
Background. Serum creatinine concentration is an unre-
liable and insensitive marker of chronic kidney disease
(CKD). To improve CKD detection, the Australasian Crea-
tinine Consensus Working Committee recommended re-
porting of estimated glomerular filtration rate (eGFR)
using the four-variable Modification of Diet in Renal
Disease (MDRD) formula with every request for serum
creatinine concentration. The aim of this study was to eval-
uate the impact of automated laboratory reporting of eGFR
on the quantity and quality of referrals to nephrology ser-
vices in Southeast Queensland, Australia.
Methods. Outpatient referrals to a tertiary and regional
renal service, and a single private practice were prospec-
tively audited over 3–12 months prior to and 12 months
following the introduction of automated eGFR reporting
and concomitant clinician education. The appropriateness
of referrals to a nephrologist was assessed according to the
Kidney Check Australia Taskforce (KCAT) criteria. Sig-
nificant changes in the quantity and/or quality of referrals
over time were analysed by exponentially weighed moving
average (EWMA) charts with control limits based on ±3
standard deviations.
Results.Atotalof1019patientswerereferredtothecentres
duringthestudyperiod.Monthlyreferralsoverallincreased
by 40% following the introduction of eGFR reporting, and
this was most marked for the tertiary renal service (52%
above baseline). The appropriateness of nephrologist refer-
rals, as adjudicated by the KCAT criteria, fell significantly
from74.3%inthe3monthspre-eGFRreportingto65.2%in
the12monthsthereafter(P<0.05).Nevertheless,agreater
absolute number of CKD patients were appropriately being
referred for nephrologist review in the post-eGFR period
(24 versus 15 per month). Patients referred following the
introduction of eGFR were significantly more likely to be
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older (median 63.2 versus 59.3 years, P < 0.05), diabetic
(25 versus 18%, P = 0.05) and have stage 3 CKD (48%
versus 36%, P < 0.01).
Conclusion. The introduction of automated eGFR calcula-
tion has led to an overall increase in referrals with a small
but significant decrease in referral quality. The increase
in referrals was seen predominantly in older and diabetic
patients with stage 3 CKD and appeared to result in net
benefit.
Keywords: chronic kidney disease; Cockcroft–Gault
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Introduction
Chronic kidney disease (CKD) is a major global public
health problem. Over the last 25 years, while the world’s
population has grown by ∼1.5% per annum, the number of
individuals being treated with dialysis or kidney transplan-
tation has increased >8% per annum [1]. In 2000, 16% of
Australians were estimated to have CKD [2] and by 2005
this figure had risen to 20% or ∼4 million people [3]. The
incidence of CKD in the adult population was recently es-
timated at 0.9% per annum [3] and its increase has largely
been driven by population ageing and the epidemics of di-
abetes, vascular disease and obesity. Not all sectors of the
population are affected equally as there is disproportion-
ate representation in the elderly, indigenous peoples and
the socially disadvantaged [4,5]. CKD is often not asso-
ciated with significant symptoms and is unrecognized in
80–90% of cases [6,7]. Its presence is a very strong risk
factor for cardiovascular disease, such that individuals with
CKD have up to a 10- to 20-fold greater risk of cardiac
death than age- and sex-matched controls without CKD
[1,8]. Furthermore, patients with CKD are at least 20 times
more likely to die from cardiovascular disease than survive
to the point of needing dialysis or kidney transplantation
[9]. In those who do reach end-stage kidney failure, nearly
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30% are referred to a nephrologist late (within 3 months of
needing kidney replacement therapy) [10]. Early identifi-
cationandmanagement ofCKDishighlycosteffectiveand
can reduce the risk of kidney failure progression and car-
diovascular disease by 20–50% [11]. Therefore, increasing
the recognition of impaired kidney function, which is often
asymptomatic, is a key part of improving health outcomes
for patients with CKD.
Historically, the most commonly used measure of overall
kidney function in clinical practice has been serum creati-
nine concentration. Unfortunately, this measurement varies
markedly with age, gender and muscle mass and is no-
toriously insensitive for detecting mild-to-moderate kidney
failure,suchthatpatientsmaylose50%ormoreoftheirkid-
ney function before the serum creatinine value rises above
the upper limit of normal [12]. More recently, calculation
of estimated GFR (eGFR) using an empirical mathematical
formulahasbeenencouragedasasimple,rapidandreliable
means of assessing kidney function [13,14]. There are no
fewerthan47differentpredictionequationscurrentlyavail-
able,althoughthe2mostcommoninusearetheCockcroft–
Gault[15]andthefour-variableModificationofDietinRe-
nal Disease (MDRD) formulae [13,16]. The advantages of
the MDRD formula are that it only requires knowledge of
four simple indices that are readily ascertained by pathol-
ogy labs (age, gender, race, serum creatinine), does not
require knowledge of the patient’s weight (making it far
more suitable for automated laboratory reporting), does
not need correction for body surface area (and therefore
does not require knowledge of the patient’s height) and has
been generally shown to be more precise and accurate than
the Cockcroft–Gault equation when the GFR is <60 mL/
min/1.73 m2. In August 2005, the Australasian Creati-
nine Consensus Working Committee [17] recommended
reporting of the four-variable MDRD eGFR simultane-
ously with creatinine to enhance detection of CKD, thereby
facilitating the timely institution of renoprotective ther-
apies and appropriate and timely referral of patients to
nephrologists.
The aim of the present study was to prospectively assess
the impact of introduction of automated eGFR reporting
on the number, patterns and appropriateness of referrals
of CKD patients to a tertiary institution, a regional (sec-
ondary) hospital and a single private practice in Southeast
Queensland, Australia.
Methods
Data collection
Outpatient referrals to a tertiary and regional renal service,
and a single private practice were audited over 3 months
prior to and 12 months following the introduction of au-
tomated eGFR reporting to determine whether this inter-
vention influenced referral patterns overall or according to
renal service setting. The tertiary hospital, (a major hospi-
tal with a full complement of subspecialty services), served
a catchment population of approximately one million and
the secondary hospital a population of three hundred thou-
sand. The private practice (where renal services are paid
for by the patient and/or their insurance company) served
the same population as the secondary hospital but with one
othercompetingpractice.Thepre-interventionauditperiod
commencedon23May2005andendedon22August2005,
when automated laboratory reporting of eGFR was intro-
ducedbytheQueenslandHealthPathologyService(QHPS,
the sole public pathology service in Queensland). The post-
intervention audit period extended from 23 August 2005
until 22 August 2006 and took account of the introduction
of eGFR reporting in October 2005 by Queensland Medi-
cal Laboratory (QML; providing ∼80% of private pathol-
ogy testing) and in January 2006 by Sullivan & Nicolaides
Pathology (S&N; providing ∼20% of local private pathol-
ogy testing). All three laboratories together accounted for
99% of local pathology services. A more detailed analy-
sis of the impact of eGFR reporting on referral rates was
performed at the tertiary centre, which had prospectively
collected data on referrals for 15 months prior to the com-
mencement of automated laboratory reporting of eGFR.
Throughout the entire study period, an education program
was run for general practitioners and hospital staff by local
renal services and the Kidney Check Australia Taskforce
(KCAT), in the form of lectures, accredited workshops,
articles in primary care journals, addenda to pathology re-
ports, online learning, mailed information leaflets, printed
office materials and decision support systems embedded in
medical software.
Datacollectedduringtheauditincludedage,gender,rea-
son for referral, CKD stage (defined according to K/DOQI
criteria) [18], serum creatinine concentration at referral,
MDRDeGFRatreferralandthepresenceofalimitedrange
of comorbidities including hypertension (defined as sys-
tolic blood pressure >140 mmHg and/or a diastolic blood
pressure >90 mmHg), diabetes mellitus and macrovascular
disease (defined as a documented history of cerebrovas-
cular, peripheral vascular or ischaemic heart disease). The
appropriateness of referrals was determined according to
the Kidney Check Australia Taskforce criteria (Table 1).
Statistics
Results are expressed as mean ± SD for parametric contin-
uous data, median [interquartile range] for non-parametric
continuous data, and frequencies and percentages for cate-
gorical data. The distributions of categorical variables for
the two audit periods were compared using the Chi-square
test or Fisher’s exact test, as appropriate. Differences in
age, eGFR and serum creatinine concentration pre- and
post-eGFR reporting were assessed by the Mann–Whitney
Table 1. Kidney Check Australia Taskforce (KCAT) guidelines for indi-
cations for referral to a nephrologist
• eGFR <30 mL/min/1.73 m2
• Rapidly declining kidney function (15% decrease in eGFR over
3 months irrespective of baseline level)
• Proteinuria >1g/24 h
• Glomerular haematuria
• Kidney disease and hypertension that proves difficult to control
• Diabetes and eGFR <60 mL/min/1.73 m2Impact of eGFR on nephrologist referral 3847
test. Changes in the quantity and/or appropriateness of re-
ferrals over time were analysed by Poisson regression and
expressed as incident rate ratios (IRR). For referrals to the
tertiaryservice,whereauditdatawereavailableoveramuch
longer time period, changes in the quantity and/or appro-
priateness of referrals over time were analysed by exponen-
tiallyweighedmovingaverage(EWMA)chartswithcontrol
limitsbasedon±3standarddeviations.Datawereanalysed
usingthesoftwarepackagesSPSSforWindowsrelease12.0
(SPSSInc.,NorthSydney,Australia)andStata/SE9.2(Col-
lege Station, TX, USA). P values <0.05 were considered
statistically significant.
Results
Referral patterns
A total of 1019 patients were referred to study centres dur-
ing the 15 months of surveillance from 23 May 2005 to
22 August 2006. Of these, 175 patients were referred over
the 3 months prior to eGFR reporting (58.3 referrals per
month) and 844 were referred during the 12 months post-
introduction of eGFR reporting (70.3 referrals per month,
IRR1.21,95%CI1.02–1.42,P<0.05).Seventeenpatients
were <18 years and were therefore excluded from further
analysis, leaving 1002 remaining in the study. Sixty-nine
percent of the referrals were from primary care, 30% from
specialists and 1% from an unrecorded source. There was
no significant change in the referral source after eGFR
introduction.
The characteristics of referred patients included in the
study are depicted in Table 2. Monthly referral rates in-
creased by 40% following the introduction of automated
laboratory reporting of eGFR and concomitant education
(Figure 1). The increase in referral rates was most marked
for the tertiary renal service (52% above baseline). Pa-
tientsreferredpost-eGFRreportingweresignificantlymore
likelytobeslightlyolder,havelowereGFRvaluesatreferral
and have stage 3 CKD compared with those referred prior
to the intervention. Moreover, patients referred post-eGFR
reporting were significantly more likely to have diabetes
mellitus and tended to more frequently have hypertension.
No significant differences were observed between the two
groups with respect to gender, serum creatinine concentra-
tion at time of referral or the presence of macrovascular
disease. Interestingly, failure of referred patients to attend
their booked renal outpatient clinic increased significantly
from 2% to 5% following the introduction of eGFR report-
ing. The increase in the non-attendance rate was not at-
tributable to increased appointment-waiting times as these
did not change throughout the time course of this study.
No significant differences in patient characteristics were
observed between the tertiary hospital (n = 591), regional
hospital(n=146)andprivaterenalpractice(n=287)(data
not shown).
Appropriateness of nephrologist referrals
The appropriateness of nephrologist referrals, as adjudi-
cated by the KCAT criteria, fell significantly from 74.3%
Table 2. Characteristics of patients referred to renal services during the
studyperiod.Resultsareexpressedasnumber(%)ormedian(interquartile
range)
Characteristic Pre-eGFR Post-eGFR P
Follow-up time (months) 3 12 –
Number of referrals 171 831 0.024
Referral rate per month 50.3 70.3 0.024
Failure to attend 3 (2%) 44 (5%) 0.04
Age (years) 59.3 [47.0–74.1] 63.2 [51.8–76.1] 0.01
Male gender 100 (58%) 423 (52%) 0.10
Hypertension 110/161 (68%) 559/741 (75%) 0.06
Diabetes mellitus (%) 31 (18%) 209 (25%) 0.05
Macrovascular disease (%) 69 (40%) 294 (36%) 0.22
eGFR (mL/min/1.73 m2) 46.4 [24.9–67.9] 39.6 [28.2–58.6] 0.04
Serum creatinine (µmol/L) 130 [90–200] 140 [105–192] 0.19
CKD stage
1 28 (16%) 80 (10%)
2 34 (20%) 127 (15%)
3 61 (36%) 395 (48%)
4 38 (22%) 193 (23%)
5 1 0( 6 % ) 3 6( 4 % ) 0 . 0 1
KCAT adherence (%) 74.3 65.2 0.028
Fig. 1. Number of referrals per month during the course of the study.
Automated laboratory reporting of eGFR commenced after Month 3.
in the 3 months pre-eGFR reporting to 65.2% in the
12 months thereafter (IRR 0.63, 95% CI 0.48–0.82, P <
0.05) (Tables 2 and 3). Nevertheless, a greater absolute
number of CKD patients were appropriately being referred
for nephrologist review in the post-eGFR period (24 ver-
sus 15 per month). The increase in ‘inappropriate’ referrals
was largely accounted for by non-diabetic patients with an
eGFR in excess of 30 mL/min/1.73 m2. Also of interest
was the dichotomy of much higher quality referrals in the
public system than in the private sector (75% versus 60%).
The reasons for this apparent disparity are uncertain but
may relate to differences in socioeconomic background or
to differences in perceived ability to access private versus
public health care systems (for example, if primary health
care providers perceived that patient access to the public
health sector was more difficult than for the private sector,
the threshold for referral of patients to public services may
have been altered accordingly).3848 E. Noble et al.
Table 3. Reasons for referral of CKD patients to nephrologists prior to and following the introduction of automated laboratory reporting of eGFR. The
differences in reasons for referral between the two time periods were statistically significant (P < 0.001)
KCAT criteria met Referral reason Pre-eGFR (n = 171) Post-eGFR (n = 831)
Yes eGFR <30 mL/min/1.73 m2 43 (25%) 203 (24%)
Rapidly declining kidney function (15% in eGFR over 3 months 0 (0%) 2 (0%)
irrespective of baseline level)
Proteinuria >1g/24 h 18 (11%) 38 (5%)
Glomerular haematuria 19 (11%) 48 (6%)
Kidney disease and hypertension that proves difficult to control 7 (4%) 41 (5%)
Diabetes and eGFR <60 mL/min/1.73 m2 24 (14%) 107 (13%)
As deemed appropriate by nephrologist (e.g. ADPKD) 16 (9%) 95 (11%)
No CKD but eGFR >30 mL/min/1.73 m2 41 (24%) 289 (35%)
Diabetes but eGFR >60 mL/min/1.73 m2 3 (1.8%) 0 (0%)
Not defined 0 (0%) 8 (1%)
Fig. 2. EWMA graph of number of referrals to a tertiary renal centre over time. Automated laboratory reporting of eGFR was introduced at the end of
Month 15 (arrow). Upper and lower dashed lines represent the control limits (± 3 standard deviations).
Sub-group analysis of tertiary renal unit referrals
In view of the short period of time over which data were
prospectively collected for all study centres prior to eGFR
reporting, a sub-group analysis was performed of tertiary
renal unit referrals for whom prospective data were avail-
able for a much longer period of over 15 months prior to
eGFR reporting. The tertiary hospital showed a significant
increase in referral rate between the two comparison pe-
riods, as demonstrated by the EWMA graph (Figure 2),
which shows the referral rate surpassing the upper con-
fidence interval 12 months after the introduction of eGFR
reporting.Theincreaseinreferralrateswassustainedoutto
1 year. There was a trend to more inappropriate referrals by
the p chart with the graph touching but not surpassing the
lower confidence limit at Month 14 of the study (Figure 3).
Discussion
The introduction of automated eGFR reporting together
with primary healthcare education significantly increased
Fig. 3. EWMA graph of the proportion of referrals to a tertiary renal
centre adhering to KCAT referral criteria over time. Automated labora-
tory reporting of eGFR was introduced at the end of Month 3 (arrow).
Upper and lower dashed lines represent the control limits (± 3 standard
deviations).Impact of eGFR on nephrologist referral 3849
the number of referrals of patients to renal services in
southeast Queensland, particularly to the tertiary renal
unit. The increase occurred predominantly after the
introduction to the private pathology services, reflecting
the utilization of these services by general practitioners
and private specialists. The majority of patients referred
had stage 3 CKD and diabetes and the increased rates of
referral reflected an increase in detection and potentially
the opportunity for earlier assessment and treatment by
specialist services. With any new guideline or tool, there is
a learning curve in its usage and there was a trend to more
inappropriate referrals, which will need to be addressed
with ongoing education.
The relative success of the pre-introduction education
undertaken can be seen by comparing the results of this
study to that of a similar study in primary care in the UK
[19]. Richards et al. [19] showed a seven-fold increase in
referrals post-introduction of automated eGFR reporting
that was then reduced back to a rate similar to that seen in
the current study, following the introduction of a referral
assessment service.
The majority of patients with mild to moderate (stages 2
and3)CKDcanandshouldbemanagedwithinthecommu-
nity by general practitioners. A subset of patients will need
to be referred to nephrologist services and it is important
thattheappropriatepatientsarereferredsothateffectiveuse
of limited outpatient resources occurs. This study showed
that although the majority of patients were appropriately
referred, there was a trend to poorer quality (Table 2), as
defined by the KCAT referral guidelines. Private practice
was the exception to this observation, improving from 40%
to 48%. Further targeted education to improve the confi-
dence of general practitioners in managing patients with
CKD will be of benefit.
There was a significant increase in people who ‘did
not attend’ (DNA) following the introduction of automated
eGFR. There is an underestimation and underappreciation
of the seriousness of CKD and its implications for general
health in the community and further education to promote
awareness of kidney disease in the community is required.
The increase in diabetics referred post-eGFR is less sur-
prising given that diabetic nephropathy is the largest cause
of ESRF in Australia [10]. The introduction of eGFR re-
porting in this study has led to an increased awareness of
CKD in diabetics that will hopefully promote greater atten-
tiontomodificationofrenalandcardiovascularriskfactors.
Given the exponentially increasing number of diabetics it
could be suggested that the KCAT indication for referral of
all diabetics with an eGFR of <60 mL/min could be fur-
ther refined, to target those with progressive albuminuria or
declining kidney function. Indeed, it is noteworthy that the
number of patients referred on the basis of significant pro-
teinuria and/or glomerular haematuria decreased following
eGFR introduction, raising the possibility of de-emphasis
of the value of urinalysis relative to eGFR in primary care.
Given that proteinuria and eGFR contribute equally im-
portant and additive information with respect to CKD risk
stratification [20], this point should receive greater empha-
sis in education programs.
The significant increase in the age of the referred pa-
tients after intervention could reflect the increasing confi-
dence interval of the MDRD equation with age, and care
needs to be taken that patients of extreme age are referred
with due consideration of the limitations of the test. Indeed,
the recently revised consensus recommendations of the
Australasian Creatinine Consensus Working Group [21]
state that
eGFR values between 45 and 59 mL/min/1.73 m2 in those
of 70 years of age and older should be interpreted with
caution. If other signs of kidney damage (e.g. proteinuria,
haematuria etc) are not present, a stable eGFR in this range
may be consistent with typical GFR for this age and an
absence of CKD related complications.
Moreover, recently published reference intervals for
eGFR in an apparently healthy Caucasian population
demonstratedthatMDRDeGFRdeclinessignificantlywith
increasing age [22]. This information has prompted some
authors to call for age to be taken into account when us-
ing eGFR for CKD diagnosis, staging and management
[23,24]. Changes to the KCAT indications for referral of
the elderly are currently being considered. Of the patients
>75 years, 20% had a normal creatinine concentration
(<120 µmol/L). Although a decreased eGFR is still pre-
dictive of an increased risk of ESRD and cardiovascular
morbidity in the setting of advanced age [25], the require-
ment for nephrologist review is debatable [7,26].
The principal limitation of the study was the relatively
short period of prospective data collection prior to the in-
troduction of eGFR reporting, which reduced the ability
to discern changes in referral rates directly attributable
to this intervention. The length of follow-up chosen was
12months post-introduction, whichmayalsohave been too
short to fully account for the growth in referral rates and
may not have reached steady state by the end of this study.
Thesecondaryandprivatecentreshadsmallerreferralareas
andwerethereforelesspoweredtoseeasignificantchange.
The private practice had one other competing practice that
did not take part in this study and may have influenced the
results. The study was not designed in a way that could
determine the impact of eGFR reporting on awareness of
CKD by the referring doctor and other studies examining
this very critical point are required. This study also did
not examine the economics of eGFR introduction. Finally,
the possibility of classification bias could not be excluded
since a previous validation study has suggested that 32.4%
of subjects were misclassified when MDRD eGFR was
used to categorize subjects according to the Kidney Dis-
ease Outcomes Quality Initiative CKD classification [27].
Such misclassification has the potential to generate pa-
tient anxiety, engender unnecessary and possibly harmful
investigation and inappropriately drain precious healthcare
resources [28].
In conclusion, automated eGFR reporting by laborato-
ries together with concomitant education significantly in-
creasedthereferralofpatientswithstage3CKDtonephrol-
ogist services and the majority of patients were referred
appropriately within the framework of the published guide-
lines. The intervention therefore resulted in net benefit.
As with any new intervention, education of primary care
clinicians plays a large role. Since the completion of this
study,anumberofadditionalmeasureshavebeeninstigated,3850 E. Noble et al.
including improved feedback to primary services and the
sending of a handbook on CKD and its management guide-
lines to referring practices in an effort to enhance the ap-
propriateness of referrals.
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